AR
ABMD

Advisory Research’s Abiomed Inc ABMD Stock Holding History

Advisory Research’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,452
Closed -$472K – 386
2018
Q4 		$472K Buy
1,452
+218
+18% +$75.7K 0.01% 299
2018
Q3 		$555K Sell
1,234
-478
-28% -$188K 0.01% 298
2018
Q2 		$700K Buy
1,712
+2
+0.1% +$725 0.01% 288
2018
Q1 		$498K Sell
1,710
-1,665
-49% -$422K 0.01% 309
2017
Q4 		$633K Sell
3,375
-9,344
-73% -$1.74M 0.01% 310
2017
Q3 		$2.14M Sell
12,719
-1,980
-13% -$299K 0.03% 211
2017
Q2 		$2.11M Sell
14,699
-13,550
-48% -$1.82M 0.03% 216
2017
Q1 		$3.54M Sell
28,249
-10,924
-28% -$1.27M 0.05% 193
2016
Q4 		$4.41M Buy
+39,173
New +$4.54M 0.07% 137

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Advisory Research's ABMD Position: Q1 2019 in Review

Advisory Research sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 1,452 shares — an estimated $472K sold.

Advisory Research first reported a position in ABMD in Q4 2016 and held it in 9 quarters. The position peaked at $4.41M in Q4 2016. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Advisory Research reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • Advisory Research sold 1,452 Abiomed Inc shares in Q1 2019, an estimated $472K.
  • Advisory Research first reported a position in Abiomed Inc in Q4 2016 and held it in 9 quarters.
  • Advisory Research's Abiomed Inc position peaked at $4.41M in Q4 2016.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Advisory Research's 13F filing for Q1 2019, filed 15 May 2019.